Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

ClinicalTrials.gov ID: NCT01748877

Public ClinicalTrials.gov record NCT01748877. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (PHN)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to investigate whether NXN-462, a selective nNOS inhibitor, is effective in reducing pain levels in patients with post-herpetic neuralgia.

Study identification

NCT ID
NCT01748877
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
NeurAxon Inc.
Industry
Enrollment
188 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2013 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Jun 19, 2014

2013 – 2014

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
22
Facility City State ZIP Site status
Premier Research Phoenix Arizona 85027 —
University of Southern California Los Angeles California 90033 —
Northern California Research Sacramento California 95821 —
Neurological Research Institute Santa Monica California — —
Meridien Research Brooksville Florida 34601 —
FPA Clinical Research Kissimmee Florida 34741 —
Suncoast Clinical Research New Port Richey Florida — —
Compass Research LLC Orlando Florida 32806 —
Meridien Research Tampa Florida 33606 —
Medex Healthcare Research, Inc. Chicago Illinois 60602 —
Integrated Clinical Trial Services West Des Moines Iowa — —
IRC Clinics Towson Maryland 21204 —
Boston Clinical Trials Boston Massachusetts 02131 —
Michigan Head-Pain and Neurological Institute Ann Arbor Michigan — —
Albuquerque Clinical Trials, Inc Albuquerque New Mexico 87102 —
Clinical Trials of America, Inc. Hickory North Carolina 01845 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Pain Specialist of Charleston, P.A. Mt. Pleasant South Carolina — —
Nashville Neuroscience Group Nashville Tennessee 37203 —
Trinity Clinical Research Tullahoma Tennessee 37388 —
ClinRx Research LLC Plano Texas 75080 —
Progressive Clinical Research San Antonio Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01748877, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01748877 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →